November 20, 2007 – Medical device maker Maquet said this week it will exhibit new SERVO-i product options and its Heliox therapeutic gas at the 53rd American Association for Respiratory Care conference, Dec. 1-3, 2007 in Orlando, FL.

Heliox is a therapeutic gas, which increases oxygenation of the lungs by eliminating a patient’s respiratory build-up of carbon dioxide. It will be shown by Maquet for the first time at the show. The maker says Heliox can be used on all patient categories and is compatible with all modes of ventilation. The Heliox option for SERVO-i is pending 510(k) review and is not yet commercially available in the U.S.

New NAVA (Neurally Adjusted Ventilatory Assist) technology, which lets the patient control the ventilator with his or her respiratory center in the brain, is a new approach to mechanical ventilation that will be available for demonstration in the Maquet booth. In addition, a NAVA breakfast symposium featuring Christer Sinderby, Ph.D. and Jennifer Beck, Ph.D. will be held Dec. 3.

The SERVO-i MR environment option is now commercially available in the U.S. An MR station will also be available in the booth to demonstrate how critically ill patients requiring advanced ventilatory care can remain on the same ventilator, whether they are in the ICU, MR examination room, or during transport.

For more information: www.maquet.com/us


Related Content

News | Image Guided Radiation Therapy (IGRT)

June 7, 2022 — Two-year results from the Dysphagia-Aspiration Related Structures (DARS) trial, which is funded by Cancer ...

Time June 07, 2022
arrow
News | Image Guided Radiation Therapy (IGRT)

May 19, 2022 — Brainlab announced that clinicians at UZ Brussel are the first to treat patients with the company’s new ...

Time May 19, 2022
arrow
News | Radiation Oncology

August 27, 2021 — For decades, the National Comprehensive Cancer Network (NCCN) recommended forgoing post-lumpectomy ...

Time August 27, 2021
arrow
News | Radiation Therapy

June 10, 2020 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...

Time June 10, 2020
arrow
News | Radiation Therapy

April 16, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time April 16, 2020
arrow
News | Image Guided Radiation Therapy (IGRT)

February 11, 2020 — Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive ...

Time February 11, 2020
arrow
News | Radiology Imaging

December 12, 2019 — Philips and the Regional Medical Center (RMC) announced a strategic 5-year partnership agreement ...

Time December 12, 2019
arrow
News | Radiation Therapy

October 22, 2019 — The American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR) ...

Time October 22, 2019
arrow
News | Image Guided Radiation Therapy (IGRT)

ViewRay Inc. announced today that patient treatments are scheduled to begin in Boston with ViewRay's MRIdian Linac System at Dana-Farber/Brigham and Women's Cancer Center. The MRIdian provides for the delivery of radiation therapy to targeted tumors while simultaneously providing continuous magnetic resonance imaging (MRI).

Time October 08, 2019
arrow
News | Image Guided Radiation Therapy (IGRT)

At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian announced Ethos therapy, an artificial intelligence (AI)-driven holistic solution designed to increase the capability, flexibility and efficiency of radiotherapy. This new solution is designed to deliver an entire adaptive treatment in a typical 15-minute timeslot, from patient setup through treatment delivery.

Time September 16, 2019
arrow
Subscribe Now